Anna Sparshatt, MPharm, MRPharmS
- 4Articles
- 17KReads
- 2007–2011Active
- 10Collaborators
- 984Citations
About
Anna Sparshatt, MPharm, MRPharmS, has published extensively on pharmacological treatments in psychiatry, focusing on schizophrenia and schizoaffective disorders as well as dementia and neurology. Her work includes reviews and analyses of antipsychotic medications such as quetiapine, aripiprazole, risperidone long-acting injections, and clozapine, examining dose relationships, plasma concentrations, receptor occupancy, and clinical outcomes. She contributed to research published between 2007 and 2011 in Psychiatrist.com.
Publications
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
